The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.
about
The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The sorafenib anti-relapse eff ...... CD279+) lymphocytes in marrow.
@en
The sorafenib anti-relapse eff ...... and accumulation of CD8+PD-1+
@nl
type
label
The sorafenib anti-relapse eff ...... CD279+) lymphocytes in marrow.
@en
The sorafenib anti-relapse eff ...... and accumulation of CD8+PD-1+
@nl
prefLabel
The sorafenib anti-relapse eff ...... CD279+) lymphocytes in marrow.
@en
The sorafenib anti-relapse eff ...... and accumulation of CD8+PD-1+
@nl
P2093
P2860
P50
P1433
P1476
The sorafenib anti-relapse eff ...... (CD279+) lymphocytes in marrow
@en
P2093
Grzegorz Dworacki
Janusz Lange
Mariola Sedzimirska
Monika Mordak-Domagala
P2860
P304
P356
10.1371/JOURNAL.PONE.0190525
P407
P577
2018-01-05T00:00:00Z